Key result
Antenatal fluorinated corticosteroids did not reduce the incidence of fetal death compared to no treatment in fetuses with congenital heart block.
Why the study?
To evaluate the outcomes of fluorinated corticosteroids, with or without other medications, for the treatment of congenital heart block in-utero.
Do antenatal fluorinated corticosteroids improve morbidity or mortality in fetuses with congenital heart block?
Systematic Review (n=740)
Yes
Do antenatal fluorinated corticosteroids improve morbidity or mortality in fetuses with congenital heart block?
Antenatal fluorinated corticosteroids do not improve fetal or neonatal mortality or morbidity in congenital heart block and are associated with increased maternal and fetal complications.
Answers are grounded in this paper and cite their sources.
Urges caution with fluorinated corticosteroids in fetal heart block; leaves open efficacy questions pending randomized trials.
OBJECTIVE: To evaluate outcomes of fluorinated corticosteroids, with or without other medications, for treatment of congenital heart block in-utero. STUDY DESIGN: A search was conducted through MEDLINE, EMBASE, WEB OF SCIENCE and SCOPUS from inception to October 2017. Only comparative studies are considered eligible. Outcomes include fetal death, downgrade of heart block, neonatal death, need for neonatal pacing, fetal and maternal complications. Random effects model was used. RESULTS: Out of 923 articles, 12 studies were eligible. Compared to no treatment, there was no significant difference in incidence of fetal death (OR 1.10, 95%CI 0.65-1.84), neonatal death (OR 0.98, 95%CI 0.41-2.33), or need for pacing (OR 1.46, 95%CI 0.78-2.74). Heart block downgrade was significantly higher in treatment group (9.48%vs.1.76%, OR 3.27, 95%CI 1.23-8.71). CONCLUSION: antenatal fluorinated corticosteroids do not improve fetal/neonatal morbidity or mortality of congenital heart block and are associated with higher incidence of fetal and maternal complications.
No takes yet. Share an insight, caveat, or question.
Michael et al. (2019) conducted a systematic review in Congenital heart block (n=740). Antenatal fluorinated corticosteroids vs. No treatment was evaluated on Fetal death (OR 1.10, 95% CI 0.65-1.84). Antenatal fluorinated corticosteroids did not reduce the incidence of fetal death compared to no treatment in fetuses with congenital heart block.
Synapse has enriched 10 related papers. Consider them for comparative context: